Publication list
2024
Nagy, N.,
Bói, B.,
Papp, G.,
Fiák, E.,
Gáspár-Kiss, E.,
Perge, B.,
Farmasi, N.,
Tarr, T.:
Antiphospholipid Antibodies Are Major Risk Factors for Non-Thrombotic Cardiac Complications in Systemic Lupus Erythematosus.
Biomedicines. 12 (3), 1-15, 2024.
Journal metrics:
Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2022)
Q1 Medicine (miscellaneous) (2022)
2023
Nagy, N.,
Papp, G.,
Gáspár-Kiss, E.,
Diószegi, Á.,
Tarr, T.:
Changes in Clinical Manifestations and Course of Systemic Lupus Erythematosus and Secondary Antiphospholipid Syndrome over Three Decades.
Biomedicines. 11 (4), 1-10, 2023.
Journal metrics:
Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2022)
Q1 Medicine (miscellaneous) (2022)
2022
Szabó, K.,
Jámbor, I.,
Pázmándi, K.,
Nagy, N.,
Papp, G.,
Tarr, T.:
Altered Circulating Follicular T Helper Cell Subsets and Follicular T Regulatory Cells Are Indicators of a Derailed B Cell Response in Lupus, Which Could Be Modified by Targeting IL-21R.
Int. J. Mol. Sci. 23 (20), 1-20, 2022.
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
Q1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
2020
2017
Tarr, T.,
Papp, G.,
Nagy, N.,
Cserép, E.,
Zeher, M.:
Chronic high-dose glucocorticoid therapy triggers the development of chronic organ damage and worsens disease outcome in systemic lupus erythematosus.
Clin. Rheumatol. 36 (2), 327-333, 2017.
Journal metrics:
Q1 Medicine (miscellaneous)
Q2 Rheumatology
updated: 2024-04-21, 01:16
